The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Personalis
Stock and Other Ownership Interests - Personalis
Patents, Royalties, Other Intellectual Property - Patent pending for use of KRAS as biomarker in pancreatic cancer. I am named as an inventor, patent owned my Personalis per employee agreement, no recurring compensation for patent specifically.
Travel, Accommodations, Expenses - Personalis
Ultra-sensitive, tumor-informed ctDNA profiling in patients with gastroesophageal cancer and treated with pembrolizumab and longitudinal ctDNA kinetics.
 
Andrew B. Nixon
Consulting or Advisory Role - AdjuVolt; Leap Therapeutics; Promega
Research Funding - AstraZeneca/MedImmune (Inst); Genentech/Roche (Inst); Genmab (Inst); HTG Molecular Diagnostics (Inst); medpacto (Inst); Promega (Inst); Seagen (Inst)
Patents, Royalties, Other Intellectual Property - Patent (Inst); Patent Pending (Inst)
 
Lee McDaniel
No Relationships to Disclose
 
Jingquan Jia
Research Funding - Bayer (Inst); Incyte (Inst); Roche/Genentech (Inst); Xilis (Inst)
 
Charles Abbott
Employment - Personalis
Stock and Other Ownership Interests - Personalis
 
Lauren Howard
Research Funding - Bayer (Inst); Diasorin (Inst); Ferring (Inst); LungLife AI (Inst); MDxHealth (Inst); Merck (Inst); Myriad Genetics (Inst); Sanofi (Inst)
 
John C. Brady
No Relationships to Disclose
 
Katherine I. Zhou
No Relationships to Disclose
 
Donna Niedzwiecki
No Relationships to Disclose
 
Richard Chen
Employment - Personalis
Leadership - Personalis
Stock and Other Ownership Interests - Personalis
Patents, Royalties, Other Intellectual Property - Multiple Personalis technology patents
Travel, Accommodations, Expenses - Personalis
 
John H Strickler
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; Beigene; Daiichi Sankyo/Astra Zeneca; GlaxoSmithKline; Inivata; Lilly; Natera (Inst); Pfizer; Pionyr; Roche/Genentech; Seagen; Silverback Therapeutics; Takeda; Viatris; Zentalis
Research Funding - A*STAR (Inst); Abbvie (Inst); Amgen (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); BeiGene; Curegenix (Inst); Daiichi Sankyo/Lilly; Erasca, Inc (Inst); Leap Therapeutics (Inst); Lilly (Inst); Nektar (Inst); Roche/Genentech (Inst); Sanofi (Inst); Seagen (Inst); Silverback Therapeutics (Inst)
Travel, Accommodations, Expenses - Seagen
 
Sean Michael Boyle
Employment - Personalis
Stock and Other Ownership Interests - Personalis
Patents, Royalties, Other Intellectual Property - I have patents though my position and work at Personalis, Inc.
 
Hope Elizabeth Uronis
Employment - GeneCentric (I)
Stock and Other Ownership Interests - GeneCentric (I)
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb/Medarex
Research Funding - Adaptimmune (Inst); Arcus Biosciences (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Leap Therapeutics (Inst); Macrogenics (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb